|
1
|
Ryerson AB, Eheman CR, Altekruse SF, Ward
JW, Jemal A, Sherman RL, Henley SJ, Holtzman D, Lake A, Noone AM,
et al: Annual report to the nation on the status of cancer,
1975–2012 featuring the increasing incidence of liver cancer.
Cancer. 122:1312–1337. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Ferlay J, Soerjomataram I, Dikshit R, Eser
S, Mathers C, Rebelo M, Parkin DM, Forman D and Bray F: Cancer
incidence and mortality worldwide: Sources, methods and major
patterns in GLOBOCAN 2012. Int J Cancer. 136:E359–E386. 2015.
View Article : Google Scholar
|
|
3
|
Gershenwald JE, Soong SJ and Balch CM;
American Joint Committee on Cancer (AJCC) Melanoma Staging
Committee: 2010.TNM staging system for cutaneous melanoma…and
beyond. Ann Surg Oncol. 17:1475–1477. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Kreppel M, Drebber U, Rothamel D, Eich HT,
Kübler A, Scheer M and Zöller JE: Prognostic impact of different
TNM-based stage groupings for oral squamous cell carcinoma. Head
Neck. 33:1467–1475. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Kolk A, Jubitz N, Mengele K, Mantwill K,
Bissinger O, Schmitt M, Kremer M and Holm PS: Expression of
Y-box-binding protein YB-1 allows stratification into long- and
short-term survivors of head and neck cancer patients. Br J Cancer.
105:1864–1873. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Götz C, Drecoll E, Straub M, Bissinger O,
Wolff KD and Kolk A: Impact of HPV infection on oral squamous cell
carcinoma. Oncotarget. 7:76704–76712. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Scully C and Bagan J: Oral squamous cell
carcinoma overview. Oral Oncol. 45:301–308. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Davidovich C and Cech TR: The recruitment
of chromatin modifiers by long noncoding RNAs: Lessons from PRC2.
RNA. 21:2007–2022. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Rogers SN, Brown JS, Woolgar JA, Lowe D,
Magennis P, Shaw RJ, Sutton D, Errington D and Vaughan D: Survival
following primary surgery for oral cancer. Oral Oncol. 45:201–211.
2009. View Article : Google Scholar
|
|
10
|
Nagtegaal ID, Quirke P and Schmoll HJ: Has
the new TNM classification for colorectal cancer improved care. Nat
Rev Clin Oncol. 9:119–123. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Piazzolla D, Palla AR, Pantoja C, Cañamero
M, de Castro IP, Ortega S, Gómez-López G, Dominguez O, Megías D,
Roncador G, et al: Lineage-restricted function of the pluripotency
factor NANOG in stratified epithelia. Nat Commun. 5:42262014.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Balch C and Nephew KP: The role of
chromatin, microRNAs, and tumor stem cells in ovarian cancer.
Cancer Biomark. 8:203–221. 2010–2011. PubMed/NCBI
|
|
13
|
Sun T: Long noncoding RNAs act as
regulators of autophagy in cancer. Pharmacol Res. 129:151–155.
2018. View Article : Google Scholar
|
|
14
|
Carvalho AL, Nishimoto IN, Califano JA and
Kowalski LP: Trends in incidence and prognosis for head and neck
cancer in the United States: A site-specific analysis of the SEER
database. Int J Cancer. 114:806–816. 2005. View Article : Google Scholar
|
|
15
|
Gutschner T and Diederichs S: The
hallmarks of cancer: A long non-coding RNA point of view. RNA Biol.
9:703–719. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Min A, Zhu C, Peng S, Rajthala S, Costea
DE and Sapkota D: MicroRNAs as important players and biomarkers in
oral carcinogenesis. Biomed Res Int. 2015.186904:2015.
|
|
17
|
Feng L, Houck JR, Lohavanichbutr P and
Chen C: Transcriptome analysis reveals differentially expressed
lncRNAs between oral squamous cellcarcinoma and healthy oral
mucosa. Oncotarget. 8:31521–31531. 2017.PubMed/NCBI
|
|
18
|
Maruyama R and Suzuki H: Long noncoding
RNA involvement in cancer. BMB Rep. 45:604–611. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Quinn JJ and Chang HY: Unique features of
long non-coding RNA biogenesis and function. Nat Rev Genet.
17:47–62. 2016. View Article : Google Scholar
|
|
20
|
Bartonicek N, Maag JL and Dinger ME: Long
noncoding RNAs in cancer: Mechanisms of action and technological
advancements. Mol Cancer. 15:432016. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Yang Q, Xu E, Dai J, Liu B, Han Z, Wu J,
Zhang S, Peng B, Zhang Y and Jiang Y: A novel long noncoding RNA
AK001796 acts as an oncogene and is involved in cell growth
inhibition by resveratrol in lung cancer. Toxicol Appl Pharmacol.
285:79–88. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Clemson CM, Hutchinson JN, Sara SA,
Ensminger AW, Fox AH, Chess A and Lawrence JB: An architectural
role for a nuclear noncoding RNA: NEAT1 RNA is essential for the
structure of paraspeckles. Mol Cell. 33:717–726. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Nie W, Ge HJ, Yang XQ, Sun X, Huang H, Tao
X, Chen WS and Li B: LncRNA-UCA1 exerts oncogenic functions in
non-small cell lung cancer by targeting miR-193a-3p. Cancer Lett.
371:99–106. 2016. View Article : Google Scholar
|
|
24
|
Peng W, Si S, Zhang Q, Li C, Zhao F, Wang
F, Yu J and Ma R: Long non-coding RNA MEG3 functions as a competing
endogenous RNA to regulate gastric cancer progression. J Exp Clin
Cancer Res. 34:792015. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
26
|
SHahinas J and Hysi D: Methods and risk of
bias in molecular marker prognosis studies in oral squamous cell
carcinoma. Oral Dis. 24:115–119. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Peurala E, Tuominen M, Löyttyniemi E,
Syrjänen S and Rautava J: Eosinophilia is a favorable prognostic
marker for oral cavity and lip squamous cell carcinoma. APMIS.
126:201–207. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Lee EY and Muller WJ: Oncogenes and tumor
suppressor genes. Cold Spring Harb Perspect Biol. 2:a0032362010.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Iurlaro R, León-Annicchiarico CL and
Muñoz-Pinedo C: Regulation of cancer metabolism by oncogenes and
tumor suppressors. Methods Enzymol. 542:59–80. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Wang D, Qiu C, Zhang H, Wang J, Cui Q and
Yin Y: Human microRNA oncogenes and tumor suppressors show
significantly different biological patterns: From functions to
targets. PLoS One. 5:e130672010. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Geisler S and Coller J: RNA in unexpected
places: Long non-coding RNA functions in diverse cellular contexts.
Nat Rev Mol Cell Biol. 14:699–712. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Han Y, Sun S, Zhao M, Zhang Z, Gong S, Gao
P, Liu J, Zhou J, Ma D, Gao Q and Wu P: CYC1 predicts poor
prognosis in patients with breast cancer. Dis Markers.
2016.3528064:2016.
|
|
33
|
Li G, Fu D, Liang W, Fan L, Chen K, Shan
L, Hu S, Ma X, Zhou K and Cheng B: CYC1 silencing sensitizes
osteosarcoma cells to TRAIL-induced apoptosis. Cell Physiol
Biochem. 34:2070–2080. 2014. View Article : Google Scholar
|
